Korea's new drugs advancing into 2005 output of 100 finished items

Domestically developed new drugs Dong's Stillen capsule, SK's Joins tablet, and Yuyu's Maxmarvil tablet ranked in 2005 output of Korea's top 100 finished drugs, according to data released by the Korea Pharmaceutical Manufacturers Association.

Stillen capsule and tablet ranked 43rd and 66th with 20.6 billion and 16.2 billion won, respectively. Joins tablet placed 88th with 13.3 billion won ...